5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like Alnylam Emerges as Winner in Rare Disease Study Showdown With Ionis November 2, 2017 Spark Therapeutics Jumps as FDA Panel Backs Breakthrough Gene Therapy October 12, 2017 Kalytera Therapeutics Announces Changes To Its Board Of Directors May 25, 2017